Author

L. Gevorkyan-Airapetov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

S. Ruthstein· 2 shared A. Gruzman· 1 shared A. Meir· 1 shared A. Munder· 1 shared F. Schwerdtfeger· 1 shared L. Hofmann· 1 shared M. Hirsch· 1 shared O. Viskind· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

S. Ruthstein

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiophysicsbioRxivPreprintAug 3, 2022

An in cell site-specific labeling methodology reveals conformational changes of proteins in bacteria

Y. Shenberger, L. Gevorkyan-Airapetov, M. Hirsch…·S. Ruthstein

This paper introduces an in-cell spin-labeling method for studying protein conformational changes in bacteria, enabling analysis of any protein size and cellular system.

DOI 10.1101/2022.08.03.502720

bacteria (other)electronic health records

𝕏 PostBluesky

BiochemistryPLOS ONEPeer-reviewedDec 30, 2019

Inhibiting the copper efflux system in microbes as a novel approach for developing antibiotics

A. Meir, V. Lepechkin-Zilbermintz, S. Kahremany…·S. Ruthstein

This study develops peptide inhibitors targeting the bacterial copper efflux system CusCFBA to combat antibiotic resistance by exploiting copper toxicity.

DOI 10.1371/journal.pone.0227070

experimental assaydrug response / drug discovery

𝕏 PostBluesky